MP

M5Invest Partners

North America, Pennsylvania, United States, Villanova

Description

M5Invest Partners is a venture capital firm that funds companies in the healthcare sector.

Investor Profile

M5Invest Partners has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does M5Invest Partners frequently co-invest with?

Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Cowtown Angels
North America, Texas, United States, Fort Worth
Co-Investments: 1
Ariel Southeast Angel Partners
North America, Georgia, United States, Savannah
Co-Investments: 1
Accelerator Fund
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1
Innovation Works
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 2
Tech Coast Angels
North America, California, United States, Newport Beach
Co-Investments: 2
Maine Angels
North America, Maine, United States, Portland
Co-Investments: 1
OC
North America, Georgia, United States, Atlanta
Co-Investments: 3
Pittsburgh Life Sciences Greenhouse
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 2
Golden Seeds
North America, New York, United States, Flushing
Co-Investments: 2

What are some of recent deals done by M5Invest Partners?

Cognition Therapeutics

Pittsburgh, Pennsylvania, United States

Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BSep 8, 2015
Amount Raised: $12,000,000
Cognition Therapeutics

Pittsburgh, Pennsylvania, United States

Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AJan 20, 2011
Amount Raised: $2,500,000
Cognition Therapeutics

Pittsburgh, Pennsylvania, United States

Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AJul 16, 2009
Amount Raised: $1,210,000